Table 3. Genes expressed less in tumours from patients in the sub-group of survivors compared with the remaining tumours  with at least two-fold change and adjusted P-value <0.05  and in tumours from all survivors compared with tumours from deceased patients with adjusted P-value <0.2

Table 2: Top 30 probe sets identified by RMA/RF that are required for accurate classification.

Table S1b. Differentially expressed genes between side population (SP) cells and CD8 T lymphocytes

Table S1a. Differentially expressed genes between side population (SP) cells and CD8 T lymphocytes

Table S3a. Differentially expressed genes between lower side population (LSP) cells and upper side population (USP) cells

Table S3b. Differentially expressed genes between lower side population (LSP) cells and upper side population (USP) cells

Table 3 Select RNAs increased in the pancreas juice of patients with pancreas cancer vs. non-cancer using U133A arrays

Table 4 Select RNAs increased in the pancreas juice of patients with pancreas cancer vs. those without cancer using X3P arrays

Table 2. Genes modified (at least 2-fold) in MDCK-Snail  -Slug  and/or -E47 compared with MDCK-CMV control cells

Table S1. Complete list of upregulated genes

Table 2. Genes down-regulated by GC treatment

Table 1. Genes up-regulated by GC treatment

Table S2. Complete list of downregulated genes

Table 3. A list of the top-10 unrestricted genes (a) and drug genes (b) were ranked using Pearson correlation and classified with ANN. +/? indicates if the gene is up or down-regulated in the group with no distant recurrences

Table 1. NanoTiO2-induced genes detected using the ?homemade? cDNA microarray (n 3)

Table S1. Genes significantly differentially expressed between NPC and MGUS

Table S2. Genes significantly differentially expressed between MGUS and MM

Table 2 Fifty-two SAM-defined genes are differentially expressed in NPC  MGUS  and MM

Table 5. Overexpressed genes in patients who remained disease free

Table 4. Overexpressed genes in patients who developed a recurrence